Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa(®) and VIVA(®) Systems

Radiofrequency ablation (RFA) is recommended in Japan for patients with hepatocellular carcinomas (HCCs) one to three in number and ≤3 cm in size. The arfa(®) and VIVA(®) RFA systems are widely used for patients with HCC and this retrospective observational study aims to compare their performances....

Descripción completa

Detalles Bibliográficos
Autores principales: Takaya, Hiroaki, Namisaki, Tadashi, Matsumoto, Kazusuke, Suzuki, Junya, Murata, Koji, Tsuji, Yuki, Nakanishi, Keisuke, Kaji, Kosuke, Kitade, Mitsuteru, Noguchi, Ryuichi, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780974/
https://www.ncbi.nlm.nih.gov/pubmed/35054128
http://dx.doi.org/10.3390/jcm11020434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780974/
https://www.ncbi.nlm.nih.gov/pubmed/35054128
http://dx.doi.org/10.3390/jcm11020434

Ejemplares similares